- Home
- INDP vs ALCE Comparison
INDP vs ALCE Comparison
Compare INDP & ALCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- ALCE
- Stock Information
- Founded
- INDP 2000
- ALCE 2019
- Country
- INDP United States
- ALCE United States
- Employees
- INDP N/A
- ALCE N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- ALCE Power Generation
- Sector
- INDP Health Care
- ALCE Utilities
- Exchange
- INDP Nasdaq
- ALCE Nasdaq
- Market Cap
- INDP 15.4M
- ALCE 13.9M
- IPO Year
- INDP N/A
- ALCE N/A
- Fundamental
- Price
- INDP $1.10
- ALCE $0.10
- Analyst Decision
- INDP Strong Buy
- ALCE
- Analyst Count
- INDP 1
- ALCE 0
- Target Price
- INDP $12.00
- ALCE N/A
- AVG Volume (30 Days)
- INDP 20.4K
- ALCE 6.4M
- Earning Date
- INDP 11-04-2024
- ALCE 11-15-2024
- Dividend Yield
- INDP N/A
- ALCE N/A
- EPS Growth
- INDP N/A
- ALCE N/A
- EPS
- INDP N/A
- ALCE N/A
- Revenue
- INDP N/A
- ALCE N/A
- Revenue This Year
- INDP N/A
- ALCE N/A
- Revenue Next Year
- INDP N/A
- ALCE N/A
- P/E Ratio
- INDP N/A
- ALCE N/A
- Revenue Growth
- INDP N/A
- ALCE N/A
- 52 Week Low
- INDP $1.03
- ALCE $0.14
- 52 Week High
- INDP $3.25
- ALCE $10.89
- Technical
- Relative Strength Index (RSI)
- INDP 36.19
- ALCE 15.16
- Support Level
- INDP $1.10
- ALCE $0.14
- Resistance Level
- INDP $1.22
- ALCE $0.32
- Average True Range (ATR)
- INDP 0.12
- ALCE 0.03
- MACD
- INDP 0.00
- ALCE -0.00
- Stochastic Oscillator
- INDP 24.00
- ALCE 0.93
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About ALCE Alternus Clean Energy Inc.
Alternus Clean Energy Inc is an international independent clean energy producer. It develops, installs, owns and operates a diverse portfolio of utility-scale solar photovoltaic power stations (PV parks) in Europe and the USA as a long-term owner. The solar parks benefit from long-term government offtake contracts and/or Power Purchase Agreements (PPAs) with investment grade off-takers, plus energy sales to local power grids. It has approximately 8 operating parks, a total of 44 MWp in operation.